Ardena, a specialist pharmaceutical contract development and manufacturing organization (CDMO) and bioanalytical CRO advancing precision medicines, announced the appointment of Paul Edwards as chief people officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
Paul Edwards as a chief people officer will reinforce its leadership team as the specialist pharmaceutical contract development and manufacturing organization and bioanalytical CRO to continue its international expansion.
If of interest, we could arrange an interview or Q&A with Paul or CEO Jeremie Trochu to explore how Ardena is aligning its people strategy with its ambitions in precision medicines and global growth.
Paul brings more than 30 years of Human Resources leadership experience in science-driven organizations and joins from Catalent Pharma Solutions, where he served as vice president, Human Resources. At Ardena, he will lead the global people strategy, with a focus on strengthening leadership capability and building a high-performance culture to support scalable growth.
Paul joins Ardena after 16 years at Catalent Pharma Solutions, where he most recently served as Vice President, Human Resources. In that role, he led international HR teams across multiple business units and geographies, shaping people strategies aligned with operational expansion, organizational design and leadership development.
At Ardena, Paul will focus on strengthening leadership capability, building a high-performance culture and ensuring the organization is structured to support productivity, speed and scalability. His mandate includes simplifying structures, clarifying accountability and developing the talent and engagement frameworks required to enable efficient execution across the business.
Jeremie Trochu, chief executive officer of Ardena, commented: “I’m delighted to welcome Paul onto our team. His track record in leading global HR organizations within the biopharma services sector makes him a very strong addition to our executive team. As Ardena continues to expand its capabilities and footprint internationally, investing in our people, leadership and culture is essential to delivering for our customers. Paul will play a key role in ensuring our organization evolves in line with our strategic ambitions.”
Paul Edwards added: “Ardena has a clear strategy and very strong scientific and technical foundations. I look forward to working with my new colleagues across the organization to further develop our leadership capability, support talent development and foster a high-performance culture that enables sustainable growth.”
Paul holds a joint honours degree in Law and Politics from Durham University in the United Kingdom and is based in New Jersey, USA.
Ardena is a specialist pharmaceutical contract development and manufacturing organization and bioanalytical CRO dedicated to advancing precision medicines. Through integrated services spanning drug substance, drug product, nanomedicines, bioanalytical services and CMC regulatory support, Ardena supports innovative and complex molecules from development to commercialization. |